Germany's pharmacists want to ease life for millions of diabetics by offering them pain-free blood glucose monitoring without taking blood as soon as possible. The Deutscher Apothekerverband e. V. (DAV; German Association of Pharmacists) and DiaMonTech GmbH, a young and innovative medical technology company, intend a strategic cooperation to significantly improve the care of diabetes patients and to take an innovative step into the future.
"The Deutscher Apothekerverband is an important partner for us as the umbrella organization with more than 19,000 pharmacies in Germany. The signing of the Letter of Intent confirms the mutual will to cooperate in a trusting and productive manner. Diabetes patients need personal care and access to the latest technology. They should be able to get both from the local pharmacy." says Thorsten Lubinski, co-founder and CEO of DiaMonTech GmbH.
The DAV and DiaMonTech are initially striving to carry out practical tests of the already CE-certified "DMT Base" in selected pharmacies. The "DMT Base" is currently optimized for use in professional environments (e.g. diabetes centers). The patient places his finger on a sensor field for a few seconds and the blood sugar is shown categorized on a display. The blood sugar level can be measured precisely and painlessly without a drop of blood. DiaMonTech thus offers a solution for diabetes patients worldwide that offers them the opportunity to significantly improve their quality of life.
The smaller "DMT Pocket" is currently in development with market launch expected by the end of 2020. This device is supposed to have the size of a smartphone and could therefore become a constant accompaniment for diabetes patients. In Germany alone, around 7.2 million people are currently affected.